Nanoflow. - OmicsDI

Show results for

Proteomics (2117)
Unknown (221)
Metabolomics (17)
Genomics (5)
Other (1)

Organisms

Saccharomyces cerevisiae (2039)
Rattus norvegicus (2039)
Homo sapiens (2039)
Shigella flexneri (2039)
Allexis (2039)
Shigella (2039)
Arabidopsis thaliana (2039)
Mus musculus (2039)
Schizosaccharomyces pombe (2038)
Sus scrofa domesticus (2038)
Staphylococcus aureus (2038)
Escherichia coli (2038)
Listeria monocytogenes (2038)
Entamoeba histolytica HM-1:IMSS-A (2038)
Solanum tuberosum (2038)
Sinorhizobium meliloti BL225C (2037)
Methylohalobius crimeensis 10Ki (2037)
Zea mays (2037)
Meleagris gallopavo (2037)
Medicago truncatula (2037)
Homo sapiens (17)
Mus musculus (3)
Saccharomyces cerevisiae (1)
Streptococcus mutans TCI-399 (1)
Gallus gallus (1)
Mus (1)
Rattus norvegicus (1)
cellular organisms (1)
Solanum lycopersicum (1)
Bos taurus (1)

Organisms

Hordeum vulgare (1)
Clostridioides difficile (1)
Saccharomyces cerevisiae (1)

Repository

pride (2040)
MassIVE (38)
MetaboLights (16)
iProX (13)
jPOST (11)
NODE (5)
PeptideAtlas (5)
ENA (5)
PanoramaPublic (3)
PAXDB (2)
geo (1)
GNPS (1)

Tissue

Cell culture (393)
Epithelial cell (152)
Brain (110)
Permanent cell line cell (80)
Blood plasma (55)
Fibroblast (55)
Lung (48)
Plant cell (47)
Whole body (46)
Leaf (44)
Blood (44)
Kidney (40)
Heart (39)
Liver (39)
Embryonic stem cell (37)
Cell suspension culture (33)
Blood cell (31)
Macrophage (30)
Skin (29)
Root (27)
T cell (26)
Blood serum (21)
B cell (21)
Colon (21)
HeLa cell (19)
Bone marrow (18)
Hepatocyte (18)
Breast (17)
Cell line (3)
Plasma (1)

Disease

Breast cancer (49)
Disease free (42)
Colon cancer (28)
Acute leukemia (24)
Cervix carcinoma (21)
Alzheimer's disease (21)
Lung adenocarcinoma (20)
Lung cancer (19)
Melanoma (17)
Malignant neoplasm of ovary (16)
Non-small cell lung carcinoma (12)
Brain cancer (11)
Glioblastoma (11)
Amyotrophic lateral sclerosis (10)
COVID-19 (10)
Prostate adenocarcinoma (9)
Osteosarcoma (8)
Acute myeloid leukemia (8)
Wounds and Injuries (7)
Huntington Disease (6)
Cardiovascular system disease (6)
Pancreatic cancer (6)
Parkinson's disease (6)
Influenza (6)
Carcinoma (5)
Progressive supranuclear palsy (5)
Stomach cancer (5)
Ovarian serous carcinoma (5)
Type 2 diabetes mellitus (5)
Triple-receptor negative breast cancer (4)

Technology Type

Mass Spectrometry (2040)
Shotgun proteomics (1090)
Bottom-up proteomics (418)
Affinity purification coupled with mass spectrometry proteomics (286)
Data-dependent acquisition (207)
Gel-based experiment (132)
Data-independent acquisition (114)
SWATH MS (79)
Top-down proteomics (51)
DiaPASEF (20)
SRM/MRM (20)
Chemical cross-linking coupled with mass spectrometry proteomics (20)
HDMSE (17)
Mass spectrometry (14)
All-ion fragmentation (10)
Affinity proteomics (8)
MSE (7)
Immunopeptidomics (6)
Mass spectrometry imaging (4)
Glycoproteomics (3)
Mass spectrometry assay (2)
Proteogenomics (2)
RNA mass spectrometry (2)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (10)
Orbitrap Exploris 480 (5)
LTQ Orbitrap Elite (4)
Q Exactive (4)
LTQ Orbitrap Velos (3)
Impact II (3)
Orbitrap Fusion Lumos (3)
LTQ XL ETD (2)
Orbitrap Eclipse (2)
Q Exactive Plus (2)
Q Exactive HF-X (2)
Liquid Chromatography MS - positive (2)
Liquid Chromatography MS - negative - reverse phase (2)
Tims TOF Pro Bruker (1)
Bruker Daltonics instrument model (1)
Autoflex III TOF/TOF smartbeam (1)
Q Exactive Orbitrap Mass Spectrometer (1)
QE (1)
QExtactive Plus (1)
MS:1000031 (1)
Orbitrap Ascend (1)
MaXis II (1)
Orbitrap Astral (1)
ZenoTOF 7600 (1)
MaXis (1)
Orbitrap Fusion (1)
Q Exactive HF (1)
LTQ Orbitrap (1)
Orbitrap Exploris 240 (1)
Direct Infusion MS - Alternating (DI-MS (Alternating)) (1)

UNIPROT ID/AC

A5C0R5_VITVI (2)
D7TBV3_VITVI (2)
F6HKB3_VITVI (2)
D7SVZ9_VITVI (2)
F6HNT7_VITVI (2)
F6HHN8_VITVI (2)
D7U187_VITVI (2)
F6HST5_VITVI (2)
A5ASC2_VITVI (2)
D7SRB4_VITVI (2)
D7UBN6_VITVI (2)
D7TZB7_VITVI (2)
D7U0C2_VITVI (2)
E0CT31_VITVI (2)
F6HLR7_VITVI (2)
F6HHD4_VITVI (2)
F6I0Z8_VITVI (2)
D7TCR2_VITVI (2)
F6H6C3_VITVI (2)
F6I115_VITVI (2)
F6GTG4_VITVI (2)
C5DB51_VITVI (2)
F6HMX8_VITVI (2)
D7TK50_VITVI (2)
D7TF52_VITVI (2)
D7TS66_VITVI (2)
F6HGH6_VITVI (2)
F6HHU0_VITVI (2)
F6H0X2_VITVI (2)
D7TTW7_VITVI (2)

CHEBI ID

CHEBI:85870 (3)
CHEBI:35038 (3)
CHEBI:84661 (3)
CHEBI:85736 (3)
CHEBI:84665 (3)
CHEBI:34494 (3)
CHEBI:16335 (3)
CHEBI:16359 (3)
CHEBI:28865 (3)
CHEBI:64563 (3)
CHEBI:143745 (2)
CHEBI:182784 (2)
CHEBI:143757 (2)
CHEBI:195271 (2)
CHEBI:134237 (2)
CHEBI:134490 (2)
CHEBI:86980 (2)
CHEBI:86974 (2)
CHEBI:85688 (2)
CHEBI:141309 (2)
CHEBI:136248 (2)
CHEBI:136257 (2)
CHEBI:136256 (2)
CHEBI:136234 (2)
CHEBI:66860 (2)
CHEBI:85737 (2)
CHEBI:85868 (2)
CHEBI:136229 (2)
CHEBI:136220 (2)
CHEBI:141297 (2)

Metabolite Name

Tris(2-butoxyethyl) phosphate (3)
Cholic acid (3)
9(10)-EpOME (3)
Adenosine (3)
Dibutyl phthalate (DBP) (2)
Lyso-PC(16:0) (2)
Alpha-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid (2)
1-({[2-(2-furylmethyl)-5-methylpyrrolidinyl]amino}methylene)-7-[8-({[2-(2-fury lmethyl)pyrrolidinyl]amino}methylene)-1,6-dihydroxy-3-methyl-5-(methylethyl)-7 -oxo(2-naphthyl)]-3,8-dihydroxy-6-methyl-4-(methylethyl)naphthalen-2-one (2)
NCGC00385123-01_C22H30O6_7b,9-Dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl acetate (2)
(2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8aR,9R,12aS,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid (2)
4-methylcytidine (2)
2-methylguanosine (2)
2'-O-methylinosine (2)
2'-O-methyluridine (2)
7-methylguanosine (2)
6-methyladenosine (2)
8-methyladenosine (2)
2-methyladenosine (2)
3-methyluridine (2)
5-methyluridine (2)
3-methylpseudouridine (2)
1-methylpseudouridine (2)
3-methylcytidine (2)
5-methylcytidine (2)
2'-O-methylguanosine (2)
2,6-Di-tert-butyl-4-hydroxymethylphenol (2)
2'-O-methylcytidine (2)
1-methylinosine (2)
1-methyladenosine (2)
Taurocholic acid (2)

First Public Date

2023 (2)
2013 (2)
2021 (1)

Classification

bacteria (1)

Modification

2x(15)N labeled L-lysine (13)
4x(15)N labeled L-arginine (13)
57.021464 (5)
15.994915 (4)
N6 (3)
4-tetrahydrothiazine-3-carboxylic acid (3)
79.966331 (2)
-17.026549 (2)
42.010565 (2)
4 (2)
N6-dimethyl-L-lysine (2)
MTRAQ heavy (1)
31.989829 (1)
3'' (1)
4x(2)H labeled dimethylated residue (1)
-18.010565 (1)
4x(2)H labeled dimethylated L-lysine (1)
+3amu) (1)
Not available (1)

Release Date

2024 (22)
2023 (20)
2020 (20)
2025 (19)
2021 (19)
2022 (18)
2018 (14)
2013 (12)
2019 (11)
2017 (11)
2015 (9)
2014 (9)
2012 (8)
2016 (6)
2008 (6)
2010 (5)
2009 (3)
2007 (3)
2004 (3)
2026 (2)
2011 (1)

Lab affiliation

Mendel University in Brno (24)
Cancer Science Institute of Singapore (CSI), National University of Singapore (NUS) (12)
UCSF (11)
Moffitt Cancer Center Tampa, FL, USA (11)
Proteomics Center, Erasmus MC (11)
Department of Biochemistry and Molecular Biology, University of Calgary, Alberta, Canada; Department of Physiology and Pharmacology, University of Calgary, Alberta, Canada; The Hotchkiss Brain Institute, University of Calgary, Alberta, Canada; McCaig Institute for Bone and Joint Health, University of Calgary, Alberta, Canada (10)
Donnelly Centre for Cellular and Biomolecular Research, Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada (9)
Drug Discovery Moffitt Cancer Center Tampa, FL, USA (8)
University of Warwick (8)
Erasmus MC (8)
Vanderbilt University Proteomics Core (7)
Department for Biochemistry, Max F. Perutz Laboratories, University of Vienna, Dr. Bohr-Gasse 9, A-1030 (7)
Director of Women’s Health Research Women’s Service Line Inova Health System (6)
Proteomics & Metabolomics Facility, Center for Open Research Resources & Equipment University of Connecticut Storrs, CT 06269 (6)
State Key Laboratory of Genetic Engineering, Department of Biochemistry, School of Life Sciences, Fudan University, Shanghai 200438, China (6)
Department of Molecular Cell Biology, Weizmann institute of Science, Israel (5)
Centre for Cancer Cell & Molecular Biology Barts Cancer Institute Queen Mary University of London Charterhouse Square London EC1M 6BQ U.K. (5)
Centre for Cancer Cell & Molecular Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. (5)
Department of Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA (5)
Thoracic Oncology Moffitt Cancer Center Tampa, FL, USA (5)
Baylor College of Medicine (5)
Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium (5)
Department of Molecular Biology and Radiobiology, Mendel University in Brno, CZ (5)
Bioplatforms Australia (5)
Imperial College London (5)
Department of Biology, University of Fribourg Chemin du Musée 10, 1700 Fribourg, Switzerland T +41 26 300 8631 (5)
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (5)
Institute of Molecular Biology (IMB) (5)
Department of Proteomics and Signal Transduction, Systems Biology of Membrane Trafficking Research Group, Max-Planck Institute of Biochemistry, Martinsried, Germany (4)
School of Biosciences University of Sheffield Sheffield, S10 2TN United Kingdom (4)

Publication date

2025 (270)
2026 (265)
2023 (253)
2024 (244)
2022 (243)
2021 (204)
2020 (166)
2018 (134)
2019 (110)
2016 (74)
2017 (73)
2015 (51)
2014 (22)
2005 (5)
2013 (2)
2007 (1)
2012 (1)
2010 (1)

2361 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

UNIPROT ID/AC

CHEBI ID

Metabolite Name

First Public Date

Classification

Modification

Release Date

Lab affiliation

Publication date

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets